Cargando…
Caution and clarity required in the use of chloroquine for COVID-19
Autores principales: | Wong, Yin Kwan, Yang, Jing, He, Yingke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270824/ https://www.ncbi.nlm.nih.gov/pubmed/32518920 http://dx.doi.org/10.1016/S2665-9913(20)30093-X |
Ejemplares similares
-
CAUTION WITH CHLOROQUINE: A CASE OF CHLOROQUINE CARDIOTOXICITY
por: Pelter, Megan, et al.
Publicado: (2023) -
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings
por: Abena, Pascale M., et al.
Publicado: (2020) -
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022) -
MRONJ and COVID-19 caution
por: Hasan, A., et al.
Publicado: (2021) -
Use of herbal drugs to treat COVID-19 should be with caution
por: Yang, Yichang
Publicado: (2020)